Pilot Trial to Evaluate the Effect of Vitamin D on Melanocyte Biomarkers

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2012
The purpose of this study is to determine the signaling pathways and changes in gene expression in melanocytes of subjects with a history of non-melanoma skin cancer who are exposed to oral vitamin D. If vitamin D is found to inhibit a signaling pathway involved in the development of melanoma such as BRAF, a protein involved in cell proliferation, then oral vitamin D could be explored further as a chemoprevention for melanoma skin cancer.
Epistemonikos ID: 29e5b0e1a63d1a114c98a11823dd036d867694ae
First added on: May 10, 2024